ibr 140 mg Pill - white capsule/oblong, 22mm
Generic Name: ibrutinib
Pill with imprint ibr 140 mg is White, Capsule/Oblong and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics Inc.
Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Waldenström Macroglobulinemia; Graft Versus Host Disease and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ibr 140 mg
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 140 mg
- Strength
- 140 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BTK inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics Inc
- National Drug Code (NDC)
- 57962-0140
See also:
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
More about Imbruvica (ibrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (68)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.